Apotheke Adhoc13d
Alzheimer-Medikament: EMA macht Weg frei für Lecanemab
Die Hersteller des Medikaments, die Pharmaunternehmen Eisai (Japan) und Biogen (USA), hatten daraufhin eine zweite Prüfung ...
Investing15d
Biogen Inc (BIIB)
Biogen Inc Aktie und aktueller Aktienkurs: Bleiben Sie über den aktuellen Aktienkurs von Biogen Inc (BIIB) stets informiert - direkt auf dieser Seite. Behalten Sie den vor- und nachbörslichen ...
Nasdaq20d
Biogen Options Trading: A Deep Dive into Market Sentiment
Deep-pocketed investors have adopted a bullish approach towards Biogen (NASDAQ:BIIB), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga ...
Bild21d
Zug zerstört SUV: Keine Zeit zu Bremsen
externen Inhalt aktivieren Um eingebettete Inhalte anzuzeigen, ist Ihre jederzeit widerrufliche Einwilligung (über Widerruf Tracking am Seitenende) zur Verarbeitung personenbezogener Daten nötig ...
Pharmaceutical Technology23d
Biogen and Stoke Therapeutics to commercialise Dravet syndrome treatment
Zorevunersen is intended for treating Dravet syndrome. Credit: Maks_lab/Shutterstock. Biogen has entered a collaboration with Stoke Therapeutics to develop and and commercialise zorevunersen to treat ...
Business Wire24d
Biogen and Stoke Therapeutics Enter into Collaboration to Develop and Commercialize Zorevunersen for the Treatment of Dravet Syndrome, a Rare Genetic Epilepsy Associated with ...
CAMBRIDGE, Mass. & BEDFORD, Mass.--(BUSINESS WIRE)--Biogen Inc. (Nasdaq: BIIB) and Stoke Therapeutics, Inc. (Nasdaq: STOK) today announced a collaboration for the ...
Yahoo Finance24d
Biogen buys rights to Stoke’s rare epilepsy drug
Through a new deal, Biogen has bought access to a potentially first-of-its-kind drug that some doctors and analysts see as a promising treatment for a rare form of epilepsy. Biogen on Tuesday ...
Business Insider24d
Biogen price target lowered to $135 from $138 at Piper Sandler
Piper Sandler analyst David Amsellem lowered the firm’s price target on Biogen (BIIB) to $135 from $138 and keeps a Neutral rating on the shares following quarterly results. Though Biogen has ...
BioPharma Dive24d
Biogen buys rights to Stoke’s rare epilepsy drug
Through a new deal, Biogen has bought access to a potentially first-of-its-kind drug that some doctors and analysts see as a promising treatment for a rare form of epilepsy. Biogen on Tuesday agreed ...
BioSpace24d
Biogen and Stoke Strike Dravet Syndrome Co-Development Deal
Biogen’s leadership has said they aren’t eager to deal, but turns out Stoke Therapeutics had a little something in its rare disease catalog that prompted Biogen to strike. The companies will work on a ...
happyhunde25d
Die 5 besten Anti-Zug-Geschirre im Test
Damit das nicht passiert, gibt es glücklicherweise Anti-Zug-Geschirre für den Hund. Im folgenden Test stellen wir dir unsere 5 besten Anti-Zug-Geschirre vor und erklären dir, worauf du beim Kauf ...